Malignant gastrointestinal stromal tumours treated with imatinib in France: results in unselected patients

被引：0
|
作者：
Bouche, O. [1 ]
Cioffi, A. [2 ]
Rios, M. [3 ]
Blesius, A. [4 ]
Chaigneau, L. [5 ]
Ray-Coquard, I. [6 ]
Blay, J. Y.
Le Cesne, A. [2 ]
Bisot-Locard, S.
Deschaseaux, C. [7 ]
机构：
[1] CHU Reims, Serv Hepatogastroenterol & Cancerol Digest, Reims, France
[2] Inst Gustave Roussy, Villejuif, France
[3] Ctr Alexis Vautrin, Vandoeuvre Les Nancy, France
[4] Hop Enfants La Timone, Marseille, France
[5] Hop Jean Minjoz, F-25030 Besancon, France
[6] Ctr Leon Berard, Dept Oncol Med Adulte, F-69373 Lyon, France
[7] Novartis Pharmaceut, Market Access, Rueil Malmaison, France
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)72003-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：594 / 594
页数：1
相关论文
共 50 条
  • [41] Cost effectiveness of imatinib mesylate in the treatment of advanced gastrointestinal stromal tumours
    Huse, Daniel M.
    von Mehren, Margaret
    Lenhart, Gregory
    Joensuu, Heikki
    Blanke, Charles
    Feng, Weiwei
    Finkelstein, Stan
    Demetri, George
    CLINICAL DRUG INVESTIGATION, 2007, 27 (02) : 85 - 93
  • [42] KIT and PDGFRA Variants and the Survival of Patients with Gastrointestinal Stromal Tumor Treated with Adjuvant Imatinib
    Joensuu, Heikki
    CANCERS, 2023, 15 (15)
  • [43] Serum KIT and KIT ligand levels in patients with gastrointestinal stromal tumors treated with imatinib
    Bono, P
    Krause, A
    von Mehren, M
    Heinrich, MC
    Blanke, CD
    Dimitrijevic, S
    Demetri, GD
    Joensuu, H
    BLOOD, 2004, 103 (08) : 2929 - 2935
  • [44] TREATMENT PATTERNS AND COST OF CARE FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMOR (GIST) TREATED WITH IMATINIB
    Seal, B. S.
    Xia, F.
    Stafkey-Mailey, D.
    Asche, C.
    Zagadailov, E.
    Eaddy, M.
    VALUE IN HEALTH, 2014, 17 (03) : A81 - A82
  • [45] Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor
    Santachiara, Rita
    Maffei, Rossana
    Martinelli, Silvia
    Arcari, Annalisa
    Piacentini, Federico
    Trabacchi, Elena
    Alfieri, Pierluigi
    Ferrari, Angela
    Leonardi, Giovanna
    Luppi, Gabriele
    Longo, Giuseppe
    Vallisa, Daniele
    Marasca, Roberto
    Torelli, Giuseppe
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (08): : 1252 - 1255
  • [46] Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial
    Joensuu, Heikki
    Reichardt, Annette
    Eriksson, Mikael
    Hohenberger, Peter
    Boye, Kjetil
    Cameron, Silke
    Lindner, Lars H.
    Jost, Philipp J.
    Bauer, Sebastian
    Schuette, Jochen
    Lindskog, Stefan
    Kallio, Raija
    Jaakkola, Panu M.
    Goplen, Dorota
    Wardelmann, Eva
    Reichardt, Peter
    BRITISH JOURNAL OF CANCER, 2024, : 299 - 304
  • [47] Patterns of progression in gastrointestinal stromal tumor treated with imatinib mesylate
    Ryu, MH
    Lee, JL
    Chang, HM
    Kim, TW
    Kang, HJ
    Sohn, HJ
    Lee, JS
    Kang, YK
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (01) : 17 - 24
  • [48] The Marketing Authorisation (MA) for imatinib in chronic myeloid leukaemia and gastrointestinal stromal tumours imatinib in chronic myeloid leukaemia and gastrointestinal stromal tumours 20 years ago: A revolution in therapeutic innovation
    Villet, Richard
    Guilhot, Francois
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2023, 207 (06): : 746 - 748
  • [49] Severe esophagitis in a patient with gastrointestinal stromal tumor treated with imatinib
    Saponara, M.
    Di Battista, M.
    Lolli, C.
    Pantaleo, M. A.
    Azzaroli, F.
    Santini, D.
    Di Scioscio, V.
    Catena, F.
    Astorino, M.
    Maleddu, A.
    Biasco, G.
    ENDOSCOPY, 2009, 41 : E67 - E68
  • [50] Patterns of progression in gastrointestinal stromal tumor treated with imatinib mesylate
    Ryu, M. H.
    Lee, J. L.
    Chang, H. M.
    Kim, T. W.
    Kang, H. J.
    Sohn, H. J.
    Lee, J. S.
    Kang, Y. K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 346 - 346
12345